Home/Filings/4/A/0000899243-21-007181
4/A//SEC Filing

AGARWAL SUNIL 4/A

Accession 0000899243-21-007181

CIK 0001770121other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 6:50 PM ET

Size

5.8 KB

Accession

0000899243-21-007181

Insider Transaction Report

Form 4/AAmended
Period: 2021-02-03
AGARWAL SUNIL
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-03+76,68276,682 total
    Exercise: $25.00Exp: 2031-02-02Common Stock (76,682 underlying)
Footnotes (2)
  • [F1]This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.
  • [F2]The option vests and becomes exercisable as to 25% of the underlying shares on February 15, 2022 and in 36 equal monthly installments thereafter.

Issuer

Sana Biotechnology, Inc.

CIK 0001770121

Entity typeother

Related Parties

1
  • filerCIK 0001616640

Filing Metadata

Form type
4/A
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 6:50 PM ET
Size
5.8 KB